Clinical Trial Update: Carbon Ion Therapy for Peripheral Non-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating carbon ion therapy for peripheral non-small cell lung cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Carbon ion therapy (carbon ion therapy)

Snippet

Sponsor: Shanghai Proton and Heavy Ion Center | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: RECRUITING